-
1
-
-
0023395389
-
The endocrinology and developmental biology of the prostate
-
Cunha GR, Donjacour AA, Cooke PS, et al. The endocrinology and developmental biology of the prostate. Endocr Rev 1987;8:338-62.
-
(1987)
Endocr Rev
, vol.8
, pp. 338-362
-
-
Cunha, G.R.1
Donjacour, A.A.2
Cooke, P.S.3
-
2
-
-
0036645414
-
Molecular biology of the androgen receptor
-
Gelmann EP. Molecular biology of the androgen receptor. J Clin Oncol 2002;20:3001-15.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3001-3015
-
-
Gelmann, E.P.1
-
3
-
-
9644279380
-
Androgen deprivation therapy for prostate cancer: Current status and future prospects
-
Miyamoto H, Messing EM, Chang C. Androgen deprivation therapy for prostate cancer: current status and future prospects. Prostate 2004;61:332-53.
-
(2004)
Prostate
, vol.61
, pp. 332-353
-
-
Miyamoto, H.1
Messing, E.M.2
Chang, C.3
-
4
-
-
84928580276
-
The effect of castration, of estrogens, and of androgen injection on serum phosphatase in metastatic carcinoma of prostate
-
Huggins C, Hodges CV. The effect of castration, of estrogens, and of androgen injection on serum phosphatase in metastatic carcinoma of prostate. Cancer Res 1941;1:293-7.
-
(1941)
Cancer Res
, vol.1
, pp. 293-297
-
-
Huggins, C.1
Hodges, C.V.2
-
5
-
-
35148846249
-
Androgen deprivation therapy: A cornerstone in the treatment of advanced prostate cancer
-
Brawer MK. Androgen deprivation therapy: a cornerstone in the treatment of advanced prostate cancer. Rev Urol 2004;6 Suppl 8:S3-9.
-
(2004)
Rev Urol
, vol.6
, Issue.SUPPL. 8
-
-
Brawer, M.K.1
-
6
-
-
35148857911
-
Hormonal therapy in prostate cancer: Historical approaches
-
Crawford ED. Hormonal therapy in prostate cancer: historical approaches. Rev Urol 2004;6 Suppl 7:S3-11.
-
(2004)
Rev Urol
, vol.6
, Issue.SUPPL. 7
-
-
Crawford, E.D.1
-
7
-
-
35148817305
-
Androgen deprivation therapy in the treatment of advanced prostate cancer
-
Perlmutter MA, Lepor H. Androgen deprivation therapy in the treatment of advanced prostate cancer. Rev Urol 2007;9 Suppl 1:S3-8.
-
(2007)
Rev Urol
, vol.9
, Issue.SUPPL. 1
-
-
Perlmutter, M.A.1
Lepor, H.2
-
8
-
-
20344408318
-
Future directions in the treatment of androgen-independent prostate cancer
-
Petrylak DP. Future directions in the treatment of androgen-independent prostate cancer. Urology 2005;65:8-12.
-
(2005)
Urology
, vol.65
, pp. 8-12
-
-
Petrylak, D.P.1
-
9
-
-
0033660592
-
The role of steroid hormones in prostate carcinogenesis
-
Bosland MC. The role of steroid hormones in prostate carcinogenesis. J Natl Cancer Inst Monogr 2000;27:39-66.
-
(2000)
J Natl Cancer Inst Monogr
, vol.27
, pp. 39-66
-
-
Bosland, M.C.1
-
10
-
-
33847779665
-
Sex steroids and prostate carcinogenesis: Integrated, multifactorial working hypothesis
-
Bosland MC. Sex steroids and prostate carcinogenesis: integrated, multifactorial working hypothesis. Ann N Y Acad Sci 2006;1089:168-76.
-
(2006)
Ann N Y Acad Sci
, vol.1089
, pp. 168-176
-
-
Bosland, M.C.1
-
11
-
-
0029688899
-
Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models
-
Bosland MC. Hormonal factors in carcinogenesis of the prostate and testis in humans and in animal models. Prog Clin Biol Res 1996;394:309-52.
-
(1996)
Prog Clin Biol Res
, vol.394
, pp. 309-352
-
-
Bosland, M.C.1
-
12
-
-
0036185247
-
Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer
-
Furuya Y, Nozaki T, Nagakawa O, Fuse H. Low serum testosterone level predicts worse response to endocrine therapy in Japanese patients with metastatic prostate cancer. Endocr J 2002;49:85-90.
-
(2002)
Endocr J
, vol.49
, pp. 85-90
-
-
Furuya, Y.1
Nozaki, T.2
Nagakawa, O.3
Fuse, H.4
-
13
-
-
0344406150
-
Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy
-
Massengill JC, Sun L, Moul JW, et al. Pretreatment total testosterone level predicts pathological stage in patients with localized prostate cancer treated with radical prostatectomy. J Urol 2003;169:1670-5.
-
(2003)
J Urol
, vol.169
, pp. 1670-1675
-
-
Massengill, J.C.1
Sun, L.2
Moul, J.W.3
-
14
-
-
13844299328
-
Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy
-
Imamoto T, Suzuki H, Fukasawa S, et al. Pretreatment serum testosterone level as a predictive factor of pathological stage in localized prostate cancer patients treated with radical prostatectomy. Eur Urol 2005;47:308-12.
-
(2005)
Eur Urol
, vol.47
, pp. 308-312
-
-
Imamoto, T.1
Suzuki, H.2
Fukasawa, S.3
-
15
-
-
0030690915
-
Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer
-
Ribeiro M, Ruff P, Falkson G. Low serum testosterone and a younger age predict for a poor outcome in metastatic prostate cancer. Am J Clin Oncol 1997;20:605-8.
-
(1997)
Am J Clin Oncol
, vol.20
, pp. 605-608
-
-
Ribeiro, M.1
Ruff, P.2
Falkson, G.3
-
16
-
-
0033950926
-
Is low serum free testosterone a marker for high grade prostate cancer?
-
Hoffman MA, DeWolf WC, Morgentaler A. Is low serum free testosterone a marker for high grade prostate cancer? J Urol 2000;163:824-7.
-
(2000)
J Urol
, vol.163
, pp. 824-827
-
-
Hoffman, M.A.1
DeWolf, W.C.2
Morgentaler, A.3
-
17
-
-
27644452640
-
Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer
-
Titus MA, Schell MJ, Lih FB, Tomer KB, Mohler JL. Testosterone and dihydrotestosterone tissue levels in recurrent prostate cancer. Clin Cancer Res 2005;11:4653-7.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4653-4657
-
-
Titus, M.A.1
Schell, M.J.2
Lih, F.B.3
Tomer, K.B.4
Mohler, J.L.5
-
18
-
-
0034681264
-
The multiple roles of PTEN in tumor suppression
-
Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell 2000;100:387-90.
-
(2000)
Cell
, vol.100
, pp. 387-390
-
-
Di Cristofano, A.1
Pandolfi, P.P.2
-
19
-
-
30944461586
-
PTEN and GSK3h: Key regulators of progression to androgen-independent prostate cancer
-
Mulholland DJ, Dedhar S, Wu H, Nelson CC. PTEN and GSK3h: key regulators of progression to androgen-independent prostate cancer. Oncogene 2006;25:329-37.
-
(2006)
Oncogene
, vol.25
, pp. 329-337
-
-
Mulholland, D.J.1
Dedhar, S.2
Wu, H.3
Nelson, C.C.4
-
20
-
-
0038335334
-
PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling
-
Paez J, Sellers WR. PI3K/PTEN/AKT pathway. A critical mediator of oncogenic signaling. Cancer Treat Res 2003;115:145-67.
-
(2003)
Cancer Treat Res
, vol.115
, pp. 145-167
-
-
Paez, J.1
Sellers, W.R.2
-
21
-
-
0344737828
-
Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis
-
Shen MM, Abate-Shen C. Roles of the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Dev Dyn 2003;228:767-78.
-
(2003)
Dev Dyn
, vol.228
, pp. 767-778
-
-
Shen, M.M.1
Abate-Shen, C.2
-
22
-
-
0035740250
-
Chromosomal deletions and tumor suppressor genes in prostate cancer
-
Dong JT. Chromosomal deletions and tumor suppressor genes in prostate cancer. Cancer Metastasis Rev 2001;20:173-93.
-
(2001)
Cancer Metastasis Rev
, vol.20
, pp. 173-193
-
-
Dong, J.T.1
-
23
-
-
0043244937
-
Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases
-
Abate-Shen C, Banach-Petrosky WA, Sun X, et al. Nkx3.1; Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases. Cancer Res 2003;63:3886-90.
-
(2003)
Cancer Res
, vol.63
, pp. 3886-3890
-
-
Abate-Shen, C.1
Banach-Petrosky, W.A.2
Sun, X.3
-
24
-
-
33749254070
-
Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer
-
Gao H, Ouyang X, Banach-Petrosky WA, Gerald WL, Shen MM, Abate-Shen C. Combinatorial activities of Akt and B-Raf/Erk signaling in a mouse model of androgen-independent prostate cancer. Proc Natl Acad Sci U S A 2006;103:14477-82.
-
(2006)
Proc Natl Acad Sci U S A
, vol.103
, pp. 14477-14482
-
-
Gao, H.1
Ouyang, X.2
Banach-Petrosky, W.A.3
Gerald, W.L.4
Shen, M.M.5
Abate-Shen, C.6
-
25
-
-
0037022663
-
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis
-
Kim MJ, Cardiff RD, Desai N, et al. Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis. Proc Natl Acad Sci U S A 2002;99:2884-9.
-
(2002)
Proc Natl Acad Sci U S A
, vol.99
, pp. 2884-2889
-
-
Kim, M.J.1
Cardiff, R.D.2
Desai, N.3
-
26
-
-
33748038440
-
Emergence of androgen independence at early stages of prostate cancer progression in nkx3.1; pten mice
-
Gao H, Ouyang X, Banach-Petrosky WA, Shen MM, Abate-Shen C. Emergence of androgen independence at early stages of prostate cancer progression in nkx3.1; pten mice. Cancer Res 2006;66:7929-33.
-
(2006)
Cancer Res
, vol.66
, pp. 7929-7933
-
-
Gao, H.1
Ouyang, X.2
Banach-Petrosky, W.A.3
Shen, M.M.4
Abate-Shen, C.5
-
27
-
-
0036966275
-
Prostatic intraepithelial neoplasia in genetically engineered mice
-
Park JH, Walls JE, Galvez JJ, et al. Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 2002;161:727-35.
-
(2002)
Am J Pathol
, vol.161
, pp. 727-735
-
-
Park, J.H.1
Walls, J.E.2
Galvez, J.J.3
-
28
-
-
0142121516
-
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
-
Irizarry RA, Hobbs B, Collin F, et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003;4:249-64.
-
(2003)
Biostatistics
, vol.4
, pp. 249-264
-
-
Irizarry, R.A.1
Hobbs, B.2
Collin, F.3
-
29
-
-
0035829361
-
Controlling the false discovery rate in behavior genetics research
-
Benjamini Y, Drai D, Elmer G, Kafkafi N, Golani I. Controlling the false discovery rate in behavior genetics research. Behav Brain Res 2001;125:279-84.
-
(2001)
Behav Brain Res
, vol.125
, pp. 279-284
-
-
Benjamini, Y.1
Drai, D.2
Elmer, G.3
Kafkafi, N.4
Golani, I.5
-
30
-
-
30044434221
-
RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region
-
Fowler M, Borazanci E, McGhee L, et al. RUNX1 (AML-1) and RUNX2 (AML-3) cooperate with prostate-derived Ets factor to activate transcription from the PSA upstream regulatory region. J Cell Biochem 2006;97:1-17.
-
(2006)
J Cell Biochem
, vol.97
, pp. 1-17
-
-
Fowler, M.1
Borazanci, E.2
McGhee, L.3
-
31
-
-
33746512473
-
Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity
-
Lyons LS, Burnstein KL. Vav3, a Rho GTPase guanine nucleotide exchange factor, increases during progression to androgen independence in prostate cancer cells and potentiates androgen receptor transcriptional activity. Mol Endocrinol 2006;20:1061-72.
-
(2006)
Mol Endocrinol
, vol.20
, pp. 1061-1072
-
-
Lyons, L.S.1
Burnstein, K.L.2
-
32
-
-
1842612441
-
Molecular determinants of resistance to antiandrogen therapy
-
Chen CD, Welsbie DS, Tran C, et al. Molecular determinants of resistance to antiandrogen therapy. Nat Med 2004;10:33-9.
-
(2004)
Nat Med
, vol.10
, pp. 33-39
-
-
Chen, C.D.1
Welsbie, D.S.2
Tran, C.3
-
33
-
-
0037812658
-
The influence of finasteride on the development of prostate cancer
-
Thompson IM, Goodman PJ, Tangen CM, et al. The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349:215-24.
-
(2003)
N Engl J Med
, vol.349
, pp. 215-224
-
-
Thompson, I.M.1
Goodman, P.J.2
Tangen, C.M.3
|